{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:33:37Z","timestamp":1771461217513,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-13-BSV3-0011"],"award-info":[{"award-number":["ANR-13-BSV3-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00066467"],"award-info":[{"award-number":["00066467"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Vaincre la mucoviscidose and Association Gregory Lemarchal","award":["RF20160501641"],"award-info":[{"award-number":["RF20160501641"]}]},{"name":"SATT Sud-Est","award":["789-SA-16-UAM"],"award-info":[{"award-number":["789-SA-16-UAM"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.antiviral.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T20:20:28Z","timestamp":1494015628000},"page":"252-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses"],"prefix":"10.1016","volume":"143","author":[{"given":"No\u00e9mie","family":"Courtin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien Fotso","family":"Fotso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-7960","authenticated-orcid":false,"given":"Pierre","family":"Fautrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floriane","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Riteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.antiviral.2017.05.001_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4049\/jimmunol.173.1.607","article-title":"Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling","volume":"173","author":"Bae","year":"2004","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"5","key":"10.1016\/j.antiviral.2017.05.001_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/nar\/21.5.1329","article-title":"Improved specificity of RT-PCR amplifications using nested cDNA primers","volume":"21","author":"Baier","year":"1993","journal-title":"Nucleic acids Res."},{"issue":"19","key":"10.1016\/j.antiviral.2017.05.001_bib3","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1128\/JVI.01405-14","article-title":"Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication","volume":"88","author":"Berri","year":"2014","journal-title":"J.\u00a0Virol"},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.001_bib4","doi-asserted-by":"crossref","first-page":"e1003229","DOI":"10.1371\/journal.ppat.1003229","article-title":"Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis","volume":"9","author":"Berri","year":"2013","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.001_bib5","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4049\/jimmunol.0903022","article-title":"A\u00a0critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses","volume":"184","author":"Chen","year":"2010","journal-title":"J.\u00a0Immunol. Baltim. Md. 1950)"},{"issue":"46","key":"10.1016\/j.antiviral.2017.05.001_bib6","doi-asserted-by":"crossref","first-page":"43390","DOI":"10.1074\/jbc.M105289200","article-title":"Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly","volume":"276","author":"Cunningham","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2017.05.001_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V94.4.1165","article-title":"A\u00a0synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1\/LXA4R","volume":"94","author":"Deng","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in\u00a0vitro and in\u00a0vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fphar.2015.00295","article-title":"Editorial: orphan GPCRs as emerging drug targets","volume":"6","author":"Fang","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.001_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2121-5-50","article-title":"The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide","volume":"5","author":"Fu","year":"2004","journal-title":"BMC Cell Biol."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.001_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","volume":"203","author":"Hayden","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"issue":"12","key":"10.1016\/j.antiviral.2017.05.001_bib12","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Archiv. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.coviro.2012.02.013","article-title":"Pathogenesis of influenza virus infections: the good, the bad and the ugly","volume":"2","author":"Kuiken","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201406-1031OC","article-title":"Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis","volume":"191","author":"L\u00ea","year":"2015","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"11","key":"10.1016\/j.antiviral.2017.05.001_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.001_bib16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.1002340","article-title":"HCV peptide (C5A), an amphipathic\u00a0-Helical peptide of hepatitis virus C, is an activator of N-Formyl peptide receptor in human phagocytes","volume":"186","author":"Lin","year":"2011","journal-title":"J.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.001_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1462-5822.2010.01556.x","article-title":"Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion","volume":"13","author":"Marjuki","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2017.05.001_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tips.2014.03.003","article-title":"GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics","volume":"35","author":"Mujic-Delic","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"17","key":"10.1016\/j.antiviral.2017.05.001_bib19","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00780-09","article-title":"Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype","volume":"83","author":"Nedellec","year":"2009","journal-title":"J.\u00a0Virol."},{"issue":"17","key":"10.1016\/j.antiviral.2017.05.001_bib20","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1182\/blood-2014-03-562876","article-title":"Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice","volume":"124","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.001_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.001_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20021995","article-title":"Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization","volume":"198","author":"Riteau","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2017.05.001_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-5-52","article-title":"A\u00a0formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus","volume":"5","author":"Shimizu","year":"2008","journal-title":"Retrovirology"},{"issue":"12","key":"10.1016\/j.antiviral.2017.05.001_bib24","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1099\/vir.0.2008\/002188-0","article-title":"A\u00a0short amino acid sequence containing tyrosine in the N-terminal region of G protein-coupled receptors is critical for their potential use as co-receptors for human and simian immunodeficiency viruses","volume":"89","author":"Shimizu","year":"2008","journal-title":"J.\u00a0General Virol"},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.001_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bcp.2014.11.004","article-title":"The proteolytically stable peptidomimetic Pam-(Lys-\u03b2NSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2","volume":"93","author":"Skovbakke","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.05.001_bib26","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.4049\/jimmunol.162.10.5924","article-title":"T21\/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors","volume":"162","author":"Su","year":"1999","journal-title":"J.\u00a0Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.001_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jiw127","article-title":"Formyl peptide receptor 2 plays a deleterious role during influenza a virus infections","volume":"214","author":"Tcherniuk","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"issue":"5","key":"10.1016\/j.antiviral.2017.05.001_bib28","doi-asserted-by":"crossref","first-page":"e37746","DOI":"10.1371\/journal.pone.0037746","article-title":"Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia","volume":"7","author":"Verri\u00e8re","year":"2012","journal-title":"PloS one"},{"issue":"22","key":"10.1016\/j.antiviral.2017.05.001_bib29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.115.020633","article-title":"Formyl-peptide receptor 2\/3\/lipoxin A4Receptor regulates neutrophil-platelet aggregation and attenuates cerebral InflammationCLINICAL PERSPECTIVE","volume":"133","author":"Vital","year":"2016","journal-title":"Circulation"},{"issue":"5650","key":"10.1016\/j.antiviral.2017.05.001_bib30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1090350","article-title":"Are we ready for pandemic influenza?","volume":"302","author":"Webby","year":"2003","journal-title":"Sci. (New York, N.Y.)"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T23:37:49Z","timestamp":1719185869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216307938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"alternative-id":["S0166354216307938"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.001","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}